Stephanie Tilenius
About Stephanie Tilenius
Independent director of Seagate Technology Holdings plc (STX), age 58, serving since 2014. Founder and former CEO of Vida Health; currently a Board Advisor to Vida Health and a Venture Advisor to AI Fund. Recognized by the Board as an Audit Committee Financial Expert; serves on the Audit & Finance Committee. Background spans consumer internet, healthcare services, software, digital commerce, and payments, with senior roles at Google and eBay .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Vida Health, Inc. | Founder; Chief Executive Officer; now Board Advisor | CEO (2014–2023); now Board Advisor | Founded and led a mobile telemedicine platform; ongoing advisory capacity |
| Kleiner Perkins Caufield & Byers | Executive in Residence | Jun 2012 – Oct 2014 | Focused on Digital Growth Fund companies |
| Google Inc. | Vice President, Global Commerce & Payments | Feb 2010 – Jun 2012 | Oversaw digital commerce, product search, and payments |
| eBay Inc. | Various leadership roles; ultimately SVP of eBay.com and Global Products | Mar 2001 – Oct 2009 | Led core marketplace product and growth initiatives |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| AI Fund | Venture Advisor | Since Sep 2024 | Venture studio for AI-based companies |
| Tapestry, Inc. | Director (prior) | Not disclosed | Prior public board service |
| ContextLogic, Inc. | Director (prior) | Not disclosed | Prior public board service |
| Redbubble Ltd. | Director (prior) | Not disclosed | Prior public board service |
| Current public company boards | None | — | No current other public directorships |
Board Governance
- Independence and committees: Independent director; member, Audit & Finance Committee; designated Audit Committee Financial Expert by the Board .
- Tenure and engagement: Director since 2014 (11+ years as of the 2025 proxy). Each incumbent director attended at least 75% of Board and committee meetings in FY2025 .
- Meeting cadence and executive sessions:
- The Board held 4 meetings; Audit & Finance 9; Compensation & People 4; Nominating & Corporate Governance 5 in FY2025 .
- Independent directors held executive sessions at each regular Board and committee meeting .
| FY2025 Meetings | Count |
|---|---|
| Board | 4 |
| Audit & Finance | 9 |
| Compensation & People | 4 |
| Nominating & Corporate Governance | 5 |
- Independence posture and policies:
- 91% of directors are independent; all three standing committees consist solely of independent directors. Tilenius is independent under Nasdaq rules; she is one of the Board’s audit committee financial experts .
- Anti-hedging and pledging: Directors are prohibited from short sales, hedging, derivative transactions, and pledging or holding Company securities in margin accounts .
- Director share ownership guideline: 4x annual Board cash retainer; as of June 27, 2025, all non-employee directors met the guideline .
Fixed Compensation (Non-Employee Director)
- Program structure (FY2025): Cash retainer $100,000 for Board members; Audit & Finance member retainer $15,000 (Chair $35,000); Compensation & People member $10,000 (Chair $30,000); Nominating & Corporate Governance member $10,000 (Chair $20,000). Non-employee Board Chair receives $175,000 cash retainer .
- Director pay cap: Non-employee director total annual compensation capped at $750,000 (cash plus equity grant-date fair value) under the 2022 EIP, unless shareholders approve an increase .
| Fiscal Year | Fees Earned or Paid in Cash ($) | Notes |
|---|---|---|
| FY2025 | 115,000 | Matches Board member + Audit & Finance member retainers |
| FY2024 | 86,250 | Reflects a Board-approved 50% retainer cut for Q1–Q2 FY2024 |
Performance Compensation (Equity Awards to Directors)
- Annual equity: RSU grant valued at $275,000 for Board members ($350,000 for non-employee Chair), granted on election/appointment; vests on the earlier of one year from grant or next AGM (≥50 weeks); full vesting on Change of Control .
- FY2025 grant (awarded Oct 19, 2024): Tilenius grant-date fair value $294,641; 2,693 RSUs outstanding as of June 27, 2025 .
| Grant Date | Award Type | Grant Value ($) | RSUs Outstanding at 6/27/2025 | Vesting | Change of Control |
|---|---|---|---|---|---|
| Oct 19, 2024 | RSU | 294,641 | 2,693 | Earlier of 1-year or next AGM (≥50 weeks) | Accelerated full vest |
Note: Director equity is time-based RSUs (no performance metrics); therefore, no PSU/TSR/ROIC metrics apply to director awards .
Other Directorships & Interlocks
- Current public company boards: None .
- Compensation & People Committee interlocks: Company discloses none; no member had relationships requiring Item 404(a) disclosure in FY2025 .
Expertise & Qualifications
- Board-identified strengths include leadership, strategic insight, digital and e-commerce, software and data expertise, and founder experience (Vida Health). Prior senior operator roles at Google (commerce/payments) and eBay (SVP eBay.com & Global Products) .
- Audit Committee Financial Expert designation underscores financial reporting and oversight credentials .
Equity Ownership
| As-of Date | Shares Owned Directly/Indirectly | Options Exercisable ≤60 Days | RSUs Vesting ≤60 Days | Total Beneficial Ownership | % Outstanding |
|---|---|---|---|---|---|
| Aug 22, 2025 | 12,244 | — | 2,693 | 14,937 | <1% (“*”) |
| Aug 9, 2024 | 10,666 | — | — | 10,666 | <1% (“*”) |
- Pledging/hedging: Company prohibits hedging and pledging by directors .
- Ownership guideline: Non-employee directors must hold 4x annual cash retainer; all were in compliance as of June 27, 2025 .
Governance Assessment
-
Strengths
- Independence and financial oversight: Independent director and Audit & Finance member; designated Audit Committee Financial Expert, bolstering audit quality and financial risk oversight .
- Engagement: Met or exceeded the Company’s attendance expectation (≥75%); robust meeting cadence with regular executive sessions supports effective oversight .
- Alignment: Equity paid entirely in Company RSUs with vesting tied to continued service; anti-hedging/pledging policy and share ownership guideline (4x retainer) enhance alignment; Company reports directors meet guideline .
- Compensation governance: Director fees/RSUs within disclosed framework; overall say-on-pay support of 96% at 2024 AGM indicates shareholder confidence in compensation practices broadly .
-
Watch items / potential risks
- Ownership level is modest in absolute terms (14,937 shares including RSUs vesting within 60 days as of Aug 22, 2025), though guideline compliance is affirmed by the Company; continue monitoring ownership growth for enhanced “skin in the game” .
- No specific individual attendance percentage disclosed beyond “≥75%”; continue to monitor for any future attendance dips (a red flag if <75%) .
-
Conflicts and related-party exposure
- Board confirms independence and no Item 404 related-party transactions for Compensation & People Committee members; Company maintains a formal related-party transaction approval policy with NCGC oversight. No familial relationships or adverse legal proceedings disclosed for directors .
Overall, Tilenius brings relevant digital, health-tech, and platform-economy experience to Seagate’s board, complements financial oversight as an audit committee financial expert, and participates in a director pay structure aligned with shareholders (cash + time-based RSUs under anti-hedging/pledging controls). No red flags on conflicts, attendance, or trading compliance were disclosed; governance signals (committee independence, ownership guidelines, say-on-pay) are supportive of investor confidence .